TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Pharma Nord Norge AS
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
24,909
|
29,198
|
24,308 |
Financial expenses |
18
|
24
![]() |
24 |
Earnings before taxes |
726
|
881
|
761 |
Total assets |
12,902
|
15,283
|
12,372 |
Current assets |
11,636
|
13,865
|
10,951 |
Current liabilities |
12,019
|
14,195
|
11,066 |
Equity capital |
789
|
983
|
1,201 |
- share capital |
706
|
746
|
707 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
6.1%
|
6.4%
|
9.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
2.9%
|
3.0%
|
3.1% |
Return on assets (ROA) |
5.8%
|
5.9%
|
6.3% |
Current ratio |
96.8%
|
97.7%
|
99.0% |
Return on equity (ROE) |
92.0%
|
89.6%
|
63.4% |
Change turnover |
-2,755
|
3,580
|
6,164 |
Change turnover % |
-10%
|
14%
|
34% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.